Aptevo Therapeutics Inc. (NASDAQ: APVO) Stock Information | RedChip
Aptevo Therapeutics Inc. NASDAQ: APVO logo small-cap
NASDAQ: APVO

Aptevo Therapeutics Inc.

$5.19

+0.1500 (2.98%)

SEC Filings


Form Type Description Pages Date
schedule Other 1 Aug 13, 2025
10-q Quarterly Reports 64 Aug 11, 2025
8-k 8K-related 12 Aug 11, 2025
4 Insider transactions 1 Aug 08, 2025
4 Insider transactions 1 Aug 08, 2025
4 Insider transactions 1 Aug 08, 2025
4 Insider transactions 1 Aug 08, 2025
4 Insider transactions 1 Aug 08, 2025
4 Insider transactions 1 Aug 08, 2025
4 Insider transactions 1 Aug 08, 2025

Sign Up For APVO Email News Alerts

Disclosure

RedChip Companies, Inc. research reports, company profiles, and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RedChip reports, company profiles, or other investor relations materials and presentations are subject to change. RedChip Companies and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time.

RedChip Visibility is a division of RedChip Companies, Inc. and offers research services to paying clients. In the purview of Section 17(b) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention to the fact that RedChip Companies Inc. is an investor relations firm hired by certain companies to increase investor awareness to the small-cap equity community.

Stock market investing is inherently risky. RedChip Companies is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles, or in other investor relations materials or presentations that it publishes electronically or in print.

We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov and/or the Ontario Securities Commission (“OSC”) at www.osc.gov.on.ca.

Aptevo Therapeutics (APVO) is a client of RedChip Companies. APVO agreed to pay RedChip Companies, Inc. a $9,000 monthly cash fee, beginning May 2025, for 6 months of investor awareness services. APVO also agreed to pay RedChip a one-time $50,000 cash fee for a 10-day national TV ad campaign aired November 18 to November 29, 2024, a one-time $45,000 cash fee for a 10-day national TV ad campaign aired December 4 to December 17, 2024, a one-time $45,000 cash fee for a 10-day national TV ad campaign aired February 17 to February 28, 2025, and a one-time $75,000 cash fee for a four-week national TV ad campaign aired in May 2025.

Investor awareness services and programs are designed to help small-cap companies communicate their investment characteristics. RedChip investor awareness services include the preparation of a research profile(s), multimedia marketing, and other awareness services.

× Before browsing our site, please accept our cookies policy